1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HDHD2 CTRPv2 pan-cancer AAC 0.24 7e-10
mRNA MYT1 CTRPv2 pan-cancer AAC 0.22 8e-10
mRNA DUSP26 CTRPv2 pan-cancer AAC 0.23 8e-10
mRNA KIF1A CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA CRTC1 CTRPv2 pan-cancer AAC 0.22 9e-10
mRNA ZNF22 CTRPv2 pan-cancer AAC 0.25 1e-09
mRNA MARCKSL1 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA LRRC37B CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA CIC CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA TXNDC16 CTRPv2 pan-cancer AAC 0.22 1e-09
Download CSV